Advisors

• Adrian M. Di Bisceglie, MD, Medical Advisor

  Board-certified in internal medicine, gastroenterology and transplant hepatology. Past president (2014) and governing board member (2010-2015) of the American Association for the Study of Liver Disease (AASLD). Advisor and committee member with the US FDA, CDC, and NIH. Most recently served as Professor of Internal Medicine and Chief of Hepatology, Division of Gastroenterology and Hepatology at Saint Louis University.

• Lawrence Goldkind, MD, Medical and Regulatory Advisor

  Former Deputy Director and Acting Division Director, Anti-inflammatory and Analgesic Drug Product of FDA CDER. Board-certified gastroenterologist and board-certified internist.

• Stephen Harrison, MD

  Medical Director for Pinnacle Clinical Research and President of Summit Clinical Research. Visiting Professor of Hepatology at Radcliffe Department of Medicine, University of Oxford. Past Associate Editor for Hepatology and currently Associate Editor for Alimentary Pharmacology and Therapeutics. Recently retired Colonel in the United States Army with 20 years of service, serving as the Gastroenterology Consultant to the Army Surgeon General. Board certified in both Internal Medicine and Gastroenterology.

• Kris Kowdley, MD

  Director, Liver Institute NW, Washington State University; Steering Committee Co-Chair, PSC Forum.

• Gwen Melincoff, Chief Business Advisor

  Ms. Melincoff has over 25 years of leadership experience in the biotechnology and pharmaceutical industries. Her experience has spanned public and private company boards, venture financing, business development, licensing, mergers and acquisitions, research operations, marketing, and product management. Ms. Melincoff previously served as Senior VP of Business Development at Shire Pharmaceuticals. She also served as board member of Tobira Therapeutics when it was acquired by Allergan.